tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Wildlife

tanzania times : Latest News and In-depth Analysis
HomeWildlife
Wildlife

Mar 5, 2025

HONOR Unveils Groundbreaking AI-Powered Earbuds Open at MWC 2025

BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device eco

All News

Wildlife

ShengShu Technology Lays Foundation for Scalable AI Video Generation with Launch of Vidu API Offering Instant Access and Industry-leading Speed for Enterprises & Developers

SINGAPORE,Feb. 13,2025-- ShengShu Technology,a world pioneer in generative AI video,announces the API platform for its flagship video generation application,Vidu,marking a major advancement in scalabl

Feb 14, 2025

JA Solar's DeepBlue 4.0 Pro Energizes Shams Power's PV Project at Coca-Cola Faisalabad

BEIJING,Feb. 10,2025-- JA Solar\'s DeepBlue 4.0 Pro modules are at the heart of a newly completed 2.5MW PV project at Coca-Cola\'s Faisalabad facility,delivered by Shams Power. This project showcases

Feb 11, 2025

Wildlife

Vantage Joins as Titanium Sponsor at Money Expo Mexico 2025

PORT VILA,Vanuatu,Feb. 10,2025-- Vantage Markets is excited to announce its participation as a Titanium Sponsor at the highly anticipated Money Expo Mexico 2025,taking place on February 26-27 in Mexi

Feb 11, 2025

Wildlife

UBTECH Showcases its Latest Humanoid Robots and Solutions at LEAP 2025

RIYADH,Saudi Arabia,Feb. 10,2025-- As a world-leading humanoid robot enterprise,UBTECH has announced its participation at LEAP 2025 in Saudi Arabia. At this event,UBTECH will showcasethe Humanoid Robo

Feb 11, 2025

Wildlife

ACEN achieves Leadership level in CDP's climate change assessment

MANILA,Philippines,Feb. 10,2025-- ACEN has achievedLeadership level and an A− ratingfor its climate actions fromCDP,the global non-profit that assesses corporate environmental transparency and perfo

Feb 11, 2025

Wildlife

Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints

CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.

Feb 11, 2025

1 ... 3 4 5 6 7 8 9 ... 73